We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Samples Quality Improved Using Low-Vacuum Tubes

By LabMedica International staff writers
Posted on 16 Jul 2019
Print article
Image: The BD Barricor tube is a single-use, plastic evacuated tube with a mechanical separator used to collect, separate, transport and process venous blood specimens (Photo courtesy of Becton, Dickinson and Company).
Image: The BD Barricor tube is a single-use, plastic evacuated tube with a mechanical separator used to collect, separate, transport and process venous blood specimens (Photo courtesy of Becton, Dickinson and Company).
Centrifugation is a time consuming step, which contributes to increase the turnaround time (TAT) in laboratories, likewise hemolyzed samples that needs a re-sampling could delay management of patients.

So, the absence of hemolysis is one of the most important quality indicators for biochemistry as many analytes are influenced at the up or at the down with sample hemolysis. The hemolysis index is a measurement of the red color of serum. This color is normally due almost exclusively to the presence of hemoglobin, which comes from ruptured red blood cell membranes.

Medical biochemists and their colleagues at the Lapeyronie University Hospital (Montpellier, France) evaluated the impact of replacing BD vacutainer heparin lithium tube by low-vacuum BD Vacutainer Barricor tube in an emergency department (ED) on hemolysis rate and TAT. In the first phase blood tests for biochemistry were all performed using 4 mL plastic BD Vacutainer lithium heparin tubes and tubes were then centrifuged during 15 minutes  at 2,000g in an emergency dedicated Multifuge X3 FR Centrifuge.

After this first period, all 4 mL BD Vacutainer lithium heparin tubes were removed from the ED and replaced by 3.5 mL BD Vacutainer Barricor lithium heparin tubes during the one day of transition. Hemolysis Index (HI) was measured in the conventional unit (free hemoglobin mg/dL) on all tubes using the Cobas 8000 Roche test SSI-2 on a c701 module. Eight chemistry analytes were measured on the four different Cobas 8000 modules.

The scientists reported that a significantly reduced time duration between reception of sample and available results in informatics laboratory system was observed with the reduction time of centrifugation allowed by use of Barricor tube compared to regular heparin lithium tubes. A statistical significant decrease in hemolysis rate also occurred in the second period as samples with HI  less than 10 reached from 52.5% in the first period to 68.5% in the second.

The authors concluded that their study highlighted two advantages when using low-vacuum Barricor tubes which was a reduction of centrifugation time allowing improvement of laboratory TAT and a reduction of hemolyzed samples that improve sample and result quality. The study was published on June 12, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Lapeyronie University Hospital

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.